PODD Insulet Corp

Price (delayed)

$263.17

Market cap

$18.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.45

Enterprise value

$18.58B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's gross profit is up by 26% YoY and by 6% from the previous quarter
PODD's revenue is up by 20% year-on-year and by 4.2% since the previous quarter
The equity is down by 16% YoY but it is up by 8% QoQ
The EPS has plunged by 200% YoY
The company's debt rose by 40% YoY and by 2.4% QoQ

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
68.97M
Market cap
$18.15B
Enterprise value
$18.58B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
36.4
Price to sales (P/S)
17.47
EV/EBIT
683.07
EV/EBITDA
194.75
EV/Sales
17.91
Earnings
Revenue
$1.04B
EBIT
$27.2M
EBITDA
$95.4M
Free cash flow
-$164.2M
Per share
EPS
-$0.45
Free cash flow per share
-$2.38
Book value per share
$7.23
Revenue per share
$15.06
TBVPS
$27.91
Balance sheet
Total assets
$2B
Total liabilities
$1.5B
Debt
$1.29B
Equity
$497.9M
Working capital
$1.08B
Liquidity
Debt to equity
2.58
Current ratio
5.72
Quick ratio
4.25
Net debt/EBITDA
4.5
Margins
EBITDA margin
9.2%
Gross margin
67.5%
Net margin
-2.8%
Operating margin
6.7%
Efficiency
Return on assets
-1.5%
Return on equity
-5.5%
Return on invested capital
1.4%
Return on capital employed
1.5%
Return on sales
2.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
-8.38%
1 week
-10.91%
1 month
-15.65%
1 year
2.99%
YTD
2.95%
QTD
-7.41%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.04B
Gross profit
$700M
Operating income
$69M
Net income
-$29.5M
Gross margin
67.5%
Net margin
-2.8%
The company's net margin has shrunk by 185% YoY but it rose by 10% QoQ
PODD's gross profit is up by 26% YoY and by 6% from the previous quarter
The company's operating margin fell by 25% YoY but it rose by 14% QoQ
PODD's revenue is up by 20% year-on-year and by 4.2% since the previous quarter

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
P/E
N/A
P/B
36.4
P/S
17.47
EV/EBIT
683.07
EV/EBITDA
194.75
EV/Sales
17.91
The EPS has plunged by 200% YoY
PODD's price to book (P/B) is 21% less than its 5-year quarterly average of 45.9 but 7% more than its last 4 quarters average of 34.1
The equity is down by 16% YoY but it is up by 8% QoQ
PODD's price to sales (P/S) is 42% higher than its 5-year quarterly average of 12.3 but 5% lower than its last 4 quarters average of 18.4
PODD's revenue is up by 20% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Insulet business performance
The return on assets has dropped by 171% year-on-year but it has increased by 12% since the previous quarter
PODD's ROE has shrunk by 162% YoY
The ROS has plunged by 71% YoY but it has grown by 24% from the previous quarter
Insulet's return on invested capital has shrunk by 71% YoY but it has increased by 27% QoQ

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 33% higher than the total liabilities
The company's total liabilities rose by 35% YoY and by 2.5% QoQ
Insulet's quick ratio has decreased by 24% YoY and by 7% from the previous quarter
The company's debt is 158% higher than its equity
The debt to equity has soared by 66% YoY but it has decreased by 6% from the previous quarter
The company's debt rose by 40% YoY and by 2.4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.